BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22628)

  • 1. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
    Soroko FE; Mehta NB; Maxwell RA; Ferris RM; Schroeder DH
    J Pharm Pharmacol; 1977 Dec; 29(12):767-70. PubMed ID: 22628
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacologic basis for therapeutic interest in bupropion.
    Soroko FE; Maxwell RA
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):67-73. PubMed ID: 6406467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
    Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
    Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
    [No Abstract]   [Full Text] [Related]  

  • 4. Quipazine, a new type of antidepressant agent.
    Rodríguez R; Pardo EG
    Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal models used in prediction of antidepressant effects in man.
    Cooper BR; Howard JL; Soroko FE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
    Boksay IJ; Popendiker K; Weber RO; Söder A
    Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects.
    Peck AW; Bye CE; Clubley M; Henson T; Riddington C
    Br J Clin Pharmacol; 1979 May; 7(5):469-78. PubMed ID: 475943
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of Su-19789B, a unique central nervous system stimulant.
    Chernov HI; Wilson DE; Partyka DA; Bernard PS; Huebner CF
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):34-44. PubMed ID: 4393633
    [No Abstract]   [Full Text] [Related]  

  • 10. Bupropion, d-amphetamine, and amitriptyline-induced conditioned taste aversion in rats: dose effects.
    Miller DB; Miller LL
    Pharmacol Biochem Behav; 1983 May; 18(5):737-40. PubMed ID: 6407035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of 9-gamma-methylaminopropyl-9,10-dihydro-9,10-methanoanthracene-HCl (ID-9206-HCl), a new potent antidepressant.
    Fukushima H; Nakamura M; Yamamoto H
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):163-76. PubMed ID: 931463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii.
    Dubey MP; Srimal RC; Nityanand S; Dhawan BN
    J Ethnopharmacol; 1981 Jan; 3(1):1-13. PubMed ID: 7193263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclohexylphenoxy amidoximes and imidazolines with antidepressive and alpha-adrenergic activity.
    Picciòla G; Carissimi M; Ravenna F; Gentili P; Carenini G
    Arzneimittelforschung; 1979; 29(5):729-38. PubMed ID: 40574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and toxicological studies of binodaline hydrochloride.
    Jahn U; Adrian RW; Ismail S; Michos N
    Arzneimittelforschung; 1983; 33(5):726-39. PubMed ID: 6683551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion hydrochloride.
    Dufresne RL; Weber SS; Becker RE
    Drug Intell Clin Pharm; 1984 Dec; 18(12):957-64. PubMed ID: 6439541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacological effects of doxepin hydrochloride].
    Ueki S; Ogawa N; Watanabe S; Gomita Y; Araki Y
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):716-61. PubMed ID: 4676614
    [No Abstract]   [Full Text] [Related]  

  • 18. [General pharmacological effects of a psychotropic agent, doxepin hydrochloride].
    Otsuki I; Ishikawa J; Sakai M; Shimabara K; Momiyama T
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):762-99. PubMed ID: 4676615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
    Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
    Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.